Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |